US Medical Innovations to Present at the Baird 2019 Global Healthcare Conference

TAKOMA PARK, MD.– US Medical Innovations, LLC (USMI), a U.S. FDA registered life science, biomedical and robotic device company (a subsidiary of US Patent Innovations, LLC), announced today that Jerome Canady MD, Chief Executive Officer, USMI will be presenting at the Baird 2019 Global Healthcare Conference on Thursday, September 5 from 9:40 to 10:10 AM in the Morgan Suite at the Intercontinental New York Barclay, New York, NY.

USMI currently has products in over 100 hospitals world-wide and this Fall is scheduled to start the first clinical trial in the U.S. to evaluate the its Canady Cold Plasma™ Technology for the treatment of cancer.

A live audio webcast of the conference presentation, along with the accompanying presentation materials, will be made available through a link on the USMI website at www.usmedinnovations.com/upcoming-events or at http://wsw.com/webcast/baird56/umi/

About US Medical Innovations

US Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a privately-held FDA registered life science, biomedical and robotic device company. USMI is dedicated to expanding the boundaries of plasma medicine for the treatment of cancer and pioneering new surgical and robotic technologies that advance patient outcomes and improve human lives.

Contact:
Kenniah Chestnut, Esq
6930 Carroll Ave.
Takoma Park, MD 2091
301-270-0147
KChestnut@usmedinnov.com
www.usmedinnovations.com